within Pharmacolibrary.Drugs.ATC.S;

model S01GX01
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0006666666666666666,
    adminDuration  = 600,
    adminMass      = 20 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00035,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01GX01</td></tr><td>route:</td><td>inhalation</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Cromoglicic acid (also known as cromolyn sodium) is a mast cell stabilizer used to prevent allergic reactions, especially in asthma and allergic conjunctivitis. It works by inhibiting the release of histamine and other mediators from sensitized mast cells. Historically used for the prophylaxis of asthma and allergic responses, it is approved in some countries but has limited usage today due to the availability of newer therapies.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after ophthalmic (eye drop) and inhaled administration.</p><h4>References</h4><ol><li><p>Zeiss, CR (1992). Intense pharmacotherapy. <i>Chest</i> 101(6 Suppl) 407S–409S. DOI:<a href=&quot;https://doi.org/10.1378/chest.101.6_supplement.407s&quot;>10.1378/chest.101.6_supplement.407s</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1591941/&quot;>https://pubmed.ncbi.nlm.nih.gov/1591941</a></p></li><li><p>Parish, RC, &amp; Miller, LJ (1993). Nedocromil sodium. <i>The Annals of pharmacotherapy</i> 27(5) 599–606. DOI:<a href=&quot;https://doi.org/10.1177/106002809302700515&quot;>10.1177/106002809302700515</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8394165/&quot;>https://pubmed.ncbi.nlm.nih.gov/8394165</a></p></li><li><p>Neale, MG, et al., &amp; Auty, RM (1986). The pharmacokinetics of sodium cromoglycate in man after intravenous and inhalation administration. <i>British journal of clinical pharmacology</i> 22(4) 373–382. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1986.tb02905.x&quot;>10.1111/j.1365-2125.1986.tb02905.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3094571/&quot;>https://pubmed.ncbi.nlm.nih.gov/3094571</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01GX01;
